Pharmacyclics, Inc. (NASDAQ:PCYC)

CAPS Rating: 2 out of 5

A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases.

Recs

0
Player Avatar portefeuille (99.65) Submitted: 12/18/2012 10:53:43 PM : Outperform Start Price: $67.72 PCYC Score: +24.42

http://caps.fool.com/Blogs/fund-trades/779590.
http://twitter.com/portefeuillefun.

Featured Broker Partners


Advertisement